LISTEN Biotechs October surprise the precise cost of precision and breaking postpartum silence

LISTEN: Biotech’s October surprise, the precise cost of precision, and breaking postpartum silence

Why are biotech stocks in the dumps? Is the latest in cancer care overhyped? And what does "folie à deux" mean? Find out on the latest episode of our biotech…

More From BioPortfolio on "LISTEN: Biotech’s October surprise, the precise cost of precision, and breaking postpartum silence"